Q2 2024
Released Aug 8, 2024, after the close
10-Q filed Aug 8, 2024, 39 days after period end · 0001493152-24-030745
Q2 2024 · 10-Q
Revenue$3.25M$3.25M −8.3% vs Q2 2023−7.7% vs Q1 2024
Net Income-$289.00K-$289.00K N/M vs Q2 2023N/M vs Q1 2024
EPS Diluted-$0.03-$0.03 N/M vs Q2 2023N/M vs Q1 2024
Gross Profit$1,912,000−8.0%
Operating Income-$317,000N/M
Operating Cash Flowderived-$501,000N/M
Margins · derived
Gross margin58.8%+0.1 pt vs Q2 2023
Operating margin-9.7%+2.5 pt vs Q2 2023
Net margin-8.9%+3.3 pt vs Q2 2023
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $3.25M | $3.55M | $2.85M | $2.27M |
| Net Income | -$289.00K | -$433.00K | -$1.14M | -$1.13M |
| EPS Diluted | -$0.03 | -$0.04 | -$0.12 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR